A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine

NCT00000720 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Globulin, Immune
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)